| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 DCHS2 PCDHGA4 ENPP2 FAT3 ADAMTS13 ADGRV1 ITGA5 SVEP1 PCDH17 FBN2 SCUBE2 HMCN1 SCUBE3 EGFLAM DSG4 CDH1 CDH2 CDH4 AGRN | 5.20e-06 | 749 | 168 | 20 | GO:0005509 |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 5.78e-06 | 5 | 168 | 3 | GO:0030156 | |
| GeneOntologyBiologicalProcess | cell junction organization | TANC2 FN1 MYCBP2 ENPP2 SRC CNTNAP1 LAMA3 ALS2 ITGA5 SVEP1 PCDH17 PTK2B SLC8A2 CNTNAP2 PLXNA4 CNTNAP4 TRPV4 CDH1 CDH2 CDH4 AGRN TJP3 | 1.19e-05 | 974 | 166 | 22 | GO:0034330 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 2.13e-05 | 187 | 166 | 9 | GO:0007156 | |
| GeneOntologyCellularComponent | external encapsulating structure | HSPG2 FN1 LAMA1 LAMA3 ADAMTS13 PKHD1L1 SVEP1 FBN2 ANGPTL2 HMCN1 LOX SPON2 FIBCD1 EGFLAM CDH2 AGRN ADAMTSL2 | 2.56e-05 | 658 | 169 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane | 6.12e-05 | 122 | 169 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | extracellular matrix | HSPG2 FN1 LAMA1 LAMA3 ADAMTS13 SVEP1 FBN2 ANGPTL2 HMCN1 LOX SPON2 FIBCD1 EGFLAM CDH2 AGRN ADAMTSL2 | 8.79e-05 | 656 | 169 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 CDSN CNTNAP1 LAMA1 LAMA3 ITGA5 HMCN1 SV2A CNTNAP2 TRPV4 DSG4 CDH1 CDH2 CDH4 TJP3 | 9.49e-05 | 591 | 169 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | anchoring junction | HSPG2 FLNB DCHS2 CDSN GAK SRC CNTNAP1 LAMA1 LAMA3 ITGA5 PTK2B HMCN1 SV2A CNTNAP2 TRPV4 DSG4 CDH1 CDH2 CDH4 TJP3 | 1.26e-04 | 976 | 169 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | laminin-3 complex | 1.94e-04 | 3 | 169 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | radial spoke 1 | 3.86e-04 | 4 | 169 | 2 | GO:0120333 | |
| GeneOntologyCellularComponent | radial spoke 3 | 3.86e-04 | 4 | 169 | 2 | GO:0120335 | |
| GeneOntologyCellularComponent | radial spoke head 1 | 3.86e-04 | 4 | 169 | 2 | GO:0120336 | |
| GeneOntologyCellularComponent | radial spoke head 3 | 3.86e-04 | 4 | 169 | 2 | GO:0120338 | |
| GeneOntologyCellularComponent | radial spoke head | 6.39e-04 | 5 | 169 | 2 | GO:0001535 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | HSPG2 FN1 LAMA1 LAMA3 FBN2 ANGPTL2 HMCN1 LOX FIBCD1 EGFLAM CDH2 AGRN | 1.30e-03 | 530 | 169 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | manchette | 1.47e-03 | 28 | 169 | 3 | GO:0002177 | |
| GeneOntologyCellularComponent | desmosome | 1.47e-03 | 28 | 169 | 3 | GO:0030057 | |
| MousePheno | skin edema | 1.73e-05 | 53 | 145 | 6 | MP:0001786 | |
| MousePheno | limbs/digits/tail phenotype | TANC2 HSPG2 FLNB AARS1 B3GLCT SPRED2 FN1 IBSP KAT6A SRC HDAC8 TOGARAM1 TDG ADGRV1 SVEP1 FBN2 SCUBE2 EDAR SC5D SACS LOX RBFOX1 SCUBE3 SMG9 KMT2A DSG4 AGRN ADAMTSL2 MYBPC2 | 3.20e-05 | 1258 | 145 | 29 | MP:0005371 |
| MousePheno | abnormal limb morphology | TANC2 HSPG2 FLNB B3GLCT SPRED2 FN1 IBSP SRC HDAC8 TOGARAM1 TDG ADGRV1 SVEP1 FBN2 SCUBE2 EDAR SC5D SACS RBFOX1 SCUBE3 SMG9 DSG4 AGRN ADAMTSL2 MYBPC2 | 5.22e-05 | 1028 | 145 | 25 | MP:0002109 |
| Domain | LAM_G_DOMAIN | 3.84e-11 | 38 | 167 | 9 | PS50025 | |
| Domain | LamG | 1.59e-10 | 44 | 167 | 9 | SM00282 | |
| Domain | - | HSPG2 FAT3 CNTNAP1 LAMA1 LAMA3 ADGRV1 SVEP1 CNTNAP2 CNTNAP4 EGFLAM AGRN | 8.57e-10 | 95 | 167 | 11 | 2.60.120.200 |
| Domain | EGF-like_CS | HSPG2 FN1 FAT3 CNTNAP1 LAMA1 LAMA3 SVEP1 FBN2 SCUBE2 HMCN1 CNTNAP2 SCUBE3 CNTNAP4 EGFLAM AGRN SORL1 | 1.70e-09 | 261 | 167 | 16 | IPR013032 |
| Domain | Laminin_G_2 | 2.08e-09 | 40 | 167 | 8 | PF02210 | |
| Domain | Laminin_G | 2.15e-09 | 58 | 167 | 9 | IPR001791 | |
| Domain | EGF | HSPG2 FAT3 CNTNAP1 LAMA1 LAMA3 SVEP1 FBN2 SCUBE2 HMCN1 CNTNAP2 SCUBE3 CNTNAP4 EGFLAM AGRN SORL1 | 3.23e-09 | 235 | 167 | 15 | SM00181 |
| Domain | EGF-like_dom | HSPG2 FAT3 CNTNAP1 LAMA1 LAMA3 SVEP1 FBN2 SCUBE2 HMCN1 CNTNAP2 SCUBE3 CNTNAP4 EGFLAM AGRN SORL1 | 7.10e-09 | 249 | 167 | 15 | IPR000742 |
| Domain | EGF_1 | HSPG2 FN1 FAT3 CNTNAP1 LAMA1 LAMA3 SVEP1 FBN2 SCUBE2 HMCN1 CNTNAP2 SCUBE3 CNTNAP4 EGFLAM AGRN | 9.79e-09 | 255 | 167 | 15 | PS00022 |
| Domain | EGF_2 | HSPG2 FAT3 CNTNAP1 LAMA1 LAMA3 SVEP1 FBN2 SCUBE2 HMCN1 CNTNAP2 SCUBE3 CNTNAP4 EGFLAM AGRN SORL1 | 1.64e-08 | 265 | 167 | 15 | PS01186 |
| Domain | ConA-like_dom | HSPG2 FAT3 CNTNAP1 LAMA1 LAMA3 ADGRV1 TRIM14 SVEP1 TRIM16 CNTNAP2 CNTNAP4 EGFLAM AGRN | 8.86e-08 | 219 | 167 | 13 | IPR013320 |
| Domain | EGF | HSPG2 CNTNAP1 SVEP1 SCUBE2 HMCN1 CNTNAP2 SCUBE3 CNTNAP4 EGFLAM AGRN | 1.97e-07 | 126 | 167 | 10 | PF00008 |
| Domain | EGF_3 | HSPG2 FAT3 CNTNAP1 SVEP1 FBN2 SCUBE2 HMCN1 CNTNAP2 SCUBE3 CNTNAP4 EGFLAM AGRN SORL1 | 2.01e-07 | 235 | 167 | 13 | PS50026 |
| Domain | EGF_CA | 1.51e-06 | 122 | 167 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.73e-06 | 124 | 167 | 9 | IPR001881 | |
| Domain | Laminin_G_1 | 1.94e-06 | 11 | 167 | 4 | PF00054 | |
| Domain | Cadherin_CS | 6.10e-06 | 109 | 167 | 8 | IPR020894 | |
| Domain | MORN | 7.79e-06 | 15 | 167 | 4 | IPR003409 | |
| Domain | MORN | 7.79e-06 | 15 | 167 | 4 | PF02493 | |
| Domain | CADHERIN_1 | 7.97e-06 | 113 | 167 | 8 | PS00232 | |
| Domain | Cadherin | 7.97e-06 | 113 | 167 | 8 | PF00028 | |
| Domain | CADHERIN_2 | 8.51e-06 | 114 | 167 | 8 | PS50268 | |
| Domain | - | 8.51e-06 | 114 | 167 | 8 | 2.60.40.60 | |
| Domain | FIBRINOGEN_C_1 | 8.92e-06 | 32 | 167 | 5 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 8.92e-06 | 32 | 167 | 5 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 8.92e-06 | 32 | 167 | 5 | PS51406 | |
| Domain | CA | 9.07e-06 | 115 | 167 | 8 | SM00112 | |
| Domain | Cadherin-like | 9.67e-06 | 116 | 167 | 8 | IPR015919 | |
| Domain | Cadherin | 1.10e-05 | 118 | 167 | 8 | IPR002126 | |
| Domain | Cadherin_pro | 2.39e-05 | 7 | 167 | 3 | PF08758 | |
| Domain | FA58C | 3.28e-05 | 21 | 167 | 4 | SM00231 | |
| Domain | FA58C_3 | 3.28e-05 | 21 | 167 | 4 | PS50022 | |
| Domain | FA58C_1 | 3.28e-05 | 21 | 167 | 4 | PS01285 | |
| Domain | FA58C_2 | 3.28e-05 | 21 | 167 | 4 | PS01286 | |
| Domain | Cadherin_pro | 3.80e-05 | 8 | 167 | 3 | SM01055 | |
| Domain | Cadherin_pro_dom | 3.80e-05 | 8 | 167 | 3 | IPR014868 | |
| Domain | LAMININ_IVA | 3.80e-05 | 8 | 167 | 3 | PS51115 | |
| Domain | Laminin_B | 3.80e-05 | 8 | 167 | 3 | PF00052 | |
| Domain | LamB | 3.80e-05 | 8 | 167 | 3 | SM00281 | |
| Domain | Laminin_IV | 3.80e-05 | 8 | 167 | 3 | IPR000034 | |
| Domain | F5_F8_type_C | 5.70e-05 | 24 | 167 | 4 | PF00754 | |
| Domain | FA58C | 5.70e-05 | 24 | 167 | 4 | IPR000421 | |
| Domain | Cadherin_C | 6.74e-05 | 25 | 167 | 4 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 6.74e-05 | 25 | 167 | 4 | IPR000233 | |
| Domain | cEGF | 7.91e-05 | 26 | 167 | 4 | PF12662 | |
| Domain | cEGF | 7.91e-05 | 26 | 167 | 4 | IPR026823 | |
| Domain | Creatinase_N | 7.95e-05 | 2 | 167 | 2 | IPR000587 | |
| Domain | Peptidase_M24_C | 7.95e-05 | 2 | 167 | 2 | PF16188 | |
| Domain | Creatinase_N | 7.95e-05 | 2 | 167 | 2 | PF01321 | |
| Domain | Pept_M24B | 7.95e-05 | 2 | 167 | 2 | IPR033740 | |
| Domain | Peptidase_M24_C | 7.95e-05 | 2 | 167 | 2 | IPR032416 | |
| Domain | Growth_fac_rcpt_ | 8.16e-05 | 156 | 167 | 8 | IPR009030 | |
| Domain | CUB | 1.09e-04 | 53 | 167 | 5 | PS01180 | |
| Domain | Ephrin_rec_like | 1.10e-04 | 11 | 167 | 3 | PF07699 | |
| Domain | EGF_CA | 1.22e-04 | 86 | 167 | 6 | PF07645 | |
| Domain | FBG | 1.23e-04 | 29 | 167 | 4 | SM00186 | |
| Domain | Catenin_binding_dom | 1.23e-04 | 29 | 167 | 4 | IPR027397 | |
| Domain | - | 1.23e-04 | 29 | 167 | 4 | 4.10.900.10 | |
| Domain | - | 1.41e-04 | 30 | 167 | 4 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 1.41e-04 | 30 | 167 | 4 | IPR014716 | |
| Domain | EGF_LAM_2 | 1.41e-04 | 30 | 167 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 1.41e-04 | 30 | 167 | 4 | PS01248 | |
| Domain | CUB_dom | 1.55e-04 | 57 | 167 | 5 | IPR000859 | |
| Domain | Galactose-bd-like | 1.99e-04 | 94 | 167 | 6 | IPR008979 | |
| Domain | EGF_Ca-bd_CS | 2.36e-04 | 97 | 167 | 6 | IPR018097 | |
| Domain | Cu-oxidase | 2.37e-04 | 3 | 167 | 2 | PF00394 | |
| Domain | PROLINE_PEPTIDASE | 2.37e-04 | 3 | 167 | 2 | PS00491 | |
| Domain | Peptidase_M24B_aminopep-P_CS | 2.37e-04 | 3 | 167 | 2 | IPR001131 | |
| Domain | Cu-oxidase | 2.37e-04 | 3 | 167 | 2 | IPR001117 | |
| Domain | MORN | 2.38e-04 | 14 | 167 | 3 | SM00698 | |
| Domain | EGF_Lam | 2.60e-04 | 35 | 167 | 4 | SM00180 | |
| Domain | Laminin_EGF | 2.60e-04 | 35 | 167 | 4 | PF00053 | |
| Domain | EGF_CA | 2.63e-04 | 99 | 167 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.78e-04 | 100 | 167 | 6 | PS00010 | |
| Domain | - | FNDC3B HSPG2 FLNB FN1 MYCBP2 MR1 PKHD1L1 RIMBP3 HMCN1 PLXNA4 RIMBP3C EGFLAM EXOC2 RIMBP3B SORL1 MYBPC2 | 3.07e-04 | 663 | 167 | 16 | 2.60.40.10 |
| Domain | Ig_E-set | 3.44e-04 | 104 | 167 | 6 | IPR014756 | |
| Domain | Laminin_EGF | 3.59e-04 | 38 | 167 | 4 | IPR002049 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.81e-04 | 106 | 167 | 6 | IPR000152 | |
| Domain | FN3 | 4.31e-04 | 199 | 167 | 8 | PS50853 | |
| Domain | Cu-oxidase_2 | 4.71e-04 | 4 | 167 | 2 | IPR011706 | |
| Domain | His_deacetylse_1 | 4.71e-04 | 4 | 167 | 2 | IPR003084 | |
| Domain | Creatinase/Aminopeptidase_P_N | 4.71e-04 | 4 | 167 | 2 | IPR028980 | |
| Domain | Cu-oxidase_2 | 4.71e-04 | 4 | 167 | 2 | PF07731 | |
| Domain | - | 4.95e-04 | 73 | 167 | 5 | 2.60.120.260 | |
| Domain | FN3_dom | 5.96e-04 | 209 | 167 | 8 | IPR003961 | |
| Domain | Ig-like_fold | FNDC3B HSPG2 FLNB FN1 MYCBP2 MR1 PKHD1L1 RIMBP3 HMCN1 PLXNA4 RIMBP3C EGFLAM EXOC2 RIMBP3B SORL1 MYBPC2 | 6.09e-04 | 706 | 167 | 16 | IPR013783 |
| Domain | Laminin_domII | 7.81e-04 | 5 | 167 | 2 | IPR010307 | |
| Domain | Creatin/AminoP/Spt16_NTD | 7.81e-04 | 5 | 167 | 2 | IPR029149 | |
| Domain | Cu-oxidase_3 | 7.81e-04 | 5 | 167 | 2 | IPR011707 | |
| Domain | MULTICOPPER_OXIDASE1 | 7.81e-04 | 5 | 167 | 2 | PS00079 | |
| Domain | Cu_oxidase_CS | 7.81e-04 | 5 | 167 | 2 | IPR033138 | |
| Domain | Laminin_aI | 7.81e-04 | 5 | 167 | 2 | IPR009254 | |
| Domain | Laminin_I | 7.81e-04 | 5 | 167 | 2 | PF06008 | |
| Domain | Laminin_II | 7.81e-04 | 5 | 167 | 2 | PF06009 | |
| Domain | - | 7.81e-04 | 5 | 167 | 2 | 3.40.350.10 | |
| Domain | Cu-oxidase_3 | 7.81e-04 | 5 | 167 | 2 | PF07732 | |
| Domain | Cupredoxin | 9.54e-04 | 22 | 167 | 3 | IPR008972 | |
| Domain | CUB | 9.55e-04 | 49 | 167 | 4 | PF00431 | |
| Domain | CUB | 1.03e-03 | 50 | 167 | 4 | SM00042 | |
| Domain | SH3_2 | 1.05e-03 | 86 | 167 | 5 | PF07653 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 8.04e-07 | 84 | 126 | 8 | M7098 | |
| Pathway | PID_SYNDECAN_2_PATHWAY | 1.02e-05 | 33 | 126 | 5 | M240 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.93e-05 | 76 | 126 | 6 | M27219 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.82e-05 | 300 | 126 | 11 | M610 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.11e-04 | 85 | 126 | 6 | M16441 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.39e-04 | 30 | 126 | 4 | M27772 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.79e-04 | 59 | 126 | 5 | M27218 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 1.80e-04 | 32 | 126 | 4 | M165 | |
| Pathway | PID_INTEGRIN_A4B1_PATHWAY | 2.04e-04 | 33 | 126 | 4 | M277 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.93e-04 | 39 | 126 | 4 | MM14601 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.93e-04 | 39 | 126 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.93e-04 | 39 | 126 | 4 | MM15165 | |
| Pathway | WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING | 4.12e-04 | 108 | 126 | 6 | M48078 | |
| Pubmed | Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome. | 4.93e-09 | 14 | 169 | 5 | 27687499 | |
| Pubmed | SOX17 links gut endoderm morphogenesis and germ layer segregation. | 1.10e-07 | 10 | 169 | 4 | 25419850 | |
| Pubmed | 1.60e-07 | 50 | 169 | 6 | 23658023 | ||
| Pubmed | 2.58e-07 | 12 | 169 | 4 | 16750824 | ||
| Pubmed | 2.76e-07 | 29 | 169 | 5 | 22613833 | ||
| Pubmed | FLNB ZSWIM8 DCHS2 AARS1 SPRED2 FN1 MYCBP2 ENPP2 CNTNAP1 PSMB4 SESN3 TXNDC11 FN3K POLR3B RSPH1 SACS ENPP5 SNRNP70 YME1L1 AGAP1 DNMT1 AGAP3 | 3.19e-07 | 1285 | 169 | 22 | 35914814 | |
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 33144400 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 9015265 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 16461340 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 4.49e-07 | 4 | 169 | 3 | 19091768 | |
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 9.36e-07 | 16 | 169 | 4 | 17948866 | |
| Pubmed | 9.36e-07 | 16 | 169 | 4 | 11307167 | ||
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 9.81e-07 | 37 | 169 | 5 | 34323105 | |
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 11511678 | ||
| Pubmed | Cell binding specificity of mouse R-cadherin and chromosomal mapping of the gene. | 1.12e-06 | 5 | 169 | 3 | 8270638 | |
| Pubmed | Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells. | 1.12e-06 | 5 | 169 | 3 | 27420561 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 1.12e-06 | 5 | 169 | 3 | 17855024 | |
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 12865344 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 1.56e-06 | 18 | 169 | 4 | 39040056 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HSPG2 B3GLCT MYCBP2 CNTNAP1 LAMA1 MR1 GPRC5A CPT1A ITGA5 TXNDC11 FOXRED2 FBN2 SC5D LOX ANTXR1 CDH2 CPVL AGRN DNMT1 SORL1 | 1.75e-06 | 1201 | 169 | 20 | 35696571 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 HSPG2 SPRED2 MORN1 MYCBP2 KAT6A WDR70 ITGA5 SRCAP AHDC1 C6orf132 SLC45A3 PIK3C2B CDK13 CPVL AGRN GAREM1 AGAP3 TJP3 | 2.03e-06 | 1105 | 169 | 19 | 35748872 |
| Pubmed | Vector-capping: a simple method for preparing a high-quality full-length cDNA library. | 2.23e-06 | 6 | 169 | 3 | 16106752 | |
| Pubmed | Slit2/Robo4 signaling modulates HIV-1 gp120-induced lymphatic hyperpermeability. | 2.23e-06 | 6 | 169 | 3 | 22241990 | |
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 8612964 | ||
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 9226036 | ||
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 15668394 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.50e-06 | 79 | 169 | 6 | 18757743 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.82e-06 | 248 | 169 | 9 | 24006456 | |
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 9226037 | ||
| Pubmed | Genetic dissection of cadherin function during nephrogenesis. | 3.89e-06 | 7 | 169 | 3 | 11839813 | |
| Pubmed | Renal collecting system growth and function depend upon embryonic γ1 laminin expression. | 4.43e-06 | 23 | 169 | 4 | 21903675 | |
| Pubmed | PCDHGA4 SRC CNTNAP1 MTMR1 FN3K SLC8A2 HSPA12A SV2A EXOC2 AGAP1 AGAP3 | 5.20e-06 | 405 | 169 | 11 | 38187761 | |
| Pubmed | 5.30e-06 | 24 | 169 | 4 | 23920106 | ||
| Pubmed | FLNB AARS1 VRK2 GAK MYCBP2 CNTNAP1 PSMB4 GPRC5A CPT1A ITGA5 PAIP1 ARHGDIA FOXRED2 TAMM41 CLNS1A EIF3L ANTXR1 SNRNP70 HDAC1 DNMT1 | 5.52e-06 | 1297 | 169 | 20 | 33545068 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNB AARS1 EXOSC10 GAK PITRM1 WDR70 PSMB4 JMJD4 MTMR1 CPT1A TRIM14 FN3K FBN2 CLNS1A CPVL YME1L1 SORL1 | 5.96e-06 | 974 | 169 | 17 | 28675297 |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | FLNB AARS1 PSMB4 HDAC8 ADGRV1 ARHGDIA KCTD5 CLNS1A EIF3L ACAP2 CPVL HDAC1 | 6.12e-06 | 495 | 169 | 12 | 28581483 |
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 7750641 | ||
| Pubmed | Transcriptome analysis in blastocyst hatching by cDNA microarray. | 6.28e-06 | 25 | 169 | 4 | 15919778 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 7.40e-06 | 26 | 169 | 4 | 34189436 | |
| Pubmed | 9.27e-06 | 9 | 169 | 3 | 18816447 | ||
| Pubmed | HSPG2 ZSWIM8 CDSN HECW1 KAT6A IDH3B BCOR AHDC1 PCDH17 TXNDC11 SACS RBFOX1 AGRN | 9.58e-06 | 608 | 169 | 13 | 16713569 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FNDC3B FLNB AARS1 CDSN EXOSC10 FN1 MYCBP2 WDR70 PSMB4 RICTOR IDH3B SRCAP COTL1 ARHGDIA POLR3B EIF3L EXOC2 YME1L1 AGRN DNMT1 | 1.02e-05 | 1353 | 169 | 20 | 29467282 |
| Pubmed | 1.16e-05 | 29 | 169 | 4 | 30220628 | ||
| Pubmed | 1.25e-05 | 157 | 169 | 7 | 30186101 | ||
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 1.27e-05 | 219 | 169 | 8 | 31353912 | |
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 30738849 | ||
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 10713718 | ||
| Pubmed | Integrin-Mediated Focal Anchorage Drives Epithelial Zippering during Mouse Neural Tube Closure. | 1.32e-05 | 10 | 169 | 3 | 32049039 | |
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 1.34e-05 | 30 | 169 | 4 | 32882513 | |
| Pubmed | TANC2 FLNB BCOR FOXRED2 RSPH1 SLFN13 CNTNAP2 CDH1 CSPP1 KDM4B | 1.50e-05 | 371 | 169 | 10 | 15747579 | |
| Pubmed | 1.54e-05 | 64 | 169 | 5 | 22261194 | ||
| Pubmed | 1.66e-05 | 164 | 169 | 7 | 32409323 | ||
| Pubmed | 1.74e-05 | 32 | 169 | 4 | 20301301 | ||
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 1.81e-05 | 11 | 169 | 3 | 15381706 | |
| Pubmed | 1.81e-05 | 11 | 169 | 3 | 23658227 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 1.81e-05 | 11 | 169 | 3 | 7493641 | |
| Pubmed | Loss of nidogen-1 and -2 results in syndactyly and changes in limb development. | 1.81e-05 | 11 | 169 | 3 | 17023412 | |
| Pubmed | SVEP1 is an endogenous ligand for the orphan receptor PEAR1. | 1.81e-05 | 11 | 169 | 3 | 36792666 | |
| Pubmed | 1.86e-05 | 167 | 169 | 7 | 22159717 | ||
| Pubmed | TANC2 FLNB GAK FN1 CNTNAP1 MTMR1 DAPK1 IDH3B COTL1 PTK2B ARHGDIA SLC8A2 HSPA12A SACS SV2A EIF3L PLXNA4 KMT2A CDH2 AGAP3 | 2.28e-05 | 1431 | 169 | 20 | 37142655 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 1510698 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 8247017 | ||
| Pubmed | Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma. | 2.35e-05 | 2 | 169 | 2 | 25506919 | |
| Pubmed | A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. | 2.35e-05 | 2 | 169 | 2 | 8849729 | |
| Pubmed | Rescuing the N-cadherin knockout by cardiac-specific expression of N- or E-cadherin. | 2.35e-05 | 2 | 169 | 2 | 11171330 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 30829665 | ||
| Pubmed | Cadherin-mediated cell sorting not determined by binding or adhesion specificity. | 2.35e-05 | 2 | 169 | 2 | 11790800 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 21343398 | ||
| Pubmed | Prognostic significance of E-cadherin and N-cadherin expression in Gliomas. | 2.35e-05 | 2 | 169 | 2 | 28851312 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 37661113 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 14675278 | ||
| Pubmed | CDH4 suppresses the progression of salivary adenoid cystic carcinoma via E-cadherin co-expression. | 2.35e-05 | 2 | 169 | 2 | 27783992 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 28628116 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 33979097 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 12057916 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 15153430 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 36010583 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 17682057 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 9211865 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 10545236 | ||
| Pubmed | E-cadherin can replace N-cadherin during secretory-stage enamel development. | 2.35e-05 | 2 | 169 | 2 | 25014356 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 35500674 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 18515364 | ||
| Pubmed | Genome-wide analyses of human perisylvian cerebral cortical patterning. | 2.35e-05 | 2 | 169 | 2 | 17978184 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 2179554 | ||
| Pubmed | Modulation of E-Cadherin and N-Cadherin by ovarian steroids and embryonic stimuli. | 2.35e-05 | 2 | 169 | 2 | 34710830 | |
| Pubmed | The role of E and N-cadherin in the postoperative course of gonadotroph pituitary tumours. | 2.35e-05 | 2 | 169 | 2 | 30051197 | |
| Pubmed | Cell adhesion. Fibronectin and integrin knockouts come unstuck. | 2.35e-05 | 2 | 169 | 2 | 7522915 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22072429 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 25607384 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 10744074 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 28470937 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 15075377 | ||
| Pubmed | Epigenetic silencing of E- and N-cadherins in the stroma of mouse thymic lymphomas. | 2.35e-05 | 2 | 169 | 2 | 16377805 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 19919954 | ||
| Pubmed | Molecular design principles underlying β-strand swapping in the adhesive dimerization of cadherins. | 2.35e-05 | 2 | 169 | 2 | 21572446 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 26743491 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24084593 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 20451421 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 11035040 | ||
| Interaction | IGFL3 interactions | 2.07e-07 | 75 | 168 | 8 | int:IGFL3 | |
| GeneFamily | CD molecules|Type I classical cadherins | 1.68e-06 | 5 | 101 | 3 | 1185 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.09e-04 | 17 | 101 | 3 | 1291 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 1.84e-04 | 4 | 101 | 2 | 989 | |
| GeneFamily | Ankyrin repeat domain containing | 4.17e-04 | 242 | 101 | 7 | 403 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 6.37e-04 | 7 | 101 | 2 | 570 | |
| GeneFamily | ArfGAPs | 8.17e-04 | 33 | 101 | 3 | 395 | |
| GeneFamily | Zinc fingers CXXC-type | 1.97e-03 | 12 | 101 | 2 | 136 | |
| GeneFamily | Laminin subunits | 1.97e-03 | 12 | 101 | 2 | 626 | |
| GeneFamily | Fibronectin type III domain containing | 2.04e-03 | 160 | 101 | 5 | 555 | |
| GeneFamily | Dyneins, axonemal | 3.98e-03 | 17 | 101 | 2 | 536 | |
| GeneFamily | Cadherin related | 3.98e-03 | 17 | 101 | 2 | 24 | |
| GeneFamily | Aminopeptidases|CD molecules | 3.98e-03 | 17 | 101 | 2 | 104 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FN1 IBSP LAMA1 LAMA3 CDCP2 SVEP1 FBN2 HMCN1 SPON2 EGFLAM AGRN | 4.89e-08 | 191 | 169 | 11 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FN1 IBSP LAMA1 LAMA3 CDCP2 SVEP1 FBN2 HMCN1 SPON2 EGFLAM AGRN | 6.37e-08 | 196 | 169 | 11 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 FN1 IBSP LAMA1 LAMA3 CDCP2 SVEP1 FBN2 HMCN1 SPON2 EGFLAM AGRN | 2.03e-07 | 270 | 169 | 12 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 FN1 IBSP LAMA1 LAMA3 CDCP2 SVEP1 FBN2 HMCN1 SPON2 EGFLAM AGRN | 2.47e-07 | 275 | 169 | 12 | M5884 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 5.76e-06 | 40 | 169 | 5 | M5887 | |
| Coexpression | NABA_MATRISOME | HSPG2 FN1 IBSP LAMA1 LAMA3 CDCP2 ADAMTS13 SVEP1 FBN2 ANGPTL2 SCUBE2 HMCN1 LOX SPON2 PLXNA4 SCUBE3 EGFLAM AGRN ADAMTSL2 | 2.92e-05 | 1008 | 169 | 19 | MM17056 |
| Coexpression | NABA_MATRISOME | HSPG2 FN1 IBSP LAMA1 LAMA3 CDCP2 ADAMTS13 SVEP1 FBN2 ANGPTL2 SCUBE2 HMCN1 LOX SPON2 PLXNA4 SCUBE3 EGFLAM AGRN ADAMTSL2 | 3.71e-05 | 1026 | 169 | 19 | M5889 |
| Coexpression | GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP | 4.71e-05 | 199 | 169 | 8 | M8551 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN | 4.88e-05 | 200 | 169 | 8 | M9657 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | SCRT1 FN1 LAMA1 ADGRV1 CPT1A ITGA5 TRIM14 SVEP1 PCDH17 SCUBE2 HMCN1 LOX FIBCD1 PLXNA4 SCUBE3 EGFLAM FAM181B CDH1 SLC7A10 | 6.83e-05 | 1074 | 169 | 19 | M1941 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 7.10e-05 | 337 | 169 | 10 | M13206 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 7.47e-05 | 35 | 169 | 4 | MM17054 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | NAALAD2 FAT3 LAMA1 MR1 SSTR4 SVEP1 HEPH HSPA12A ANGPTL2 HMCN1 SLFN13 LOX ANTXR1 EGFLAM | 3.67e-07 | 336 | 164 | 14 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TANC2 FN1 FAT3 LAMA1 MR1 SVEP1 HEPH HSPA12A FBN2 ANGPTL2 HMCN1 RSPH1 SLFN13 SV2A LOX PLXNA4 ANTXR1 EGFLAM | 3.34e-05 | 777 | 164 | 18 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | FNDC3B SPRED2 ENPP2 LAMA1 HSPA12A FBN2 SCUBE3 ANTXR1 CDH1 CDH4 AGRN GAREM1 | 6.46e-05 | 398 | 164 | 12 | gudmap_kidney_P4_CapMesRenVes_Crym_500 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | FNDC3B HSPG2 NAALAD2 FN1 ENPP2 DAPK1 SVEP1 ANGPTL2 HMCN1 LOX SPON2 ANTXR1 ENPP5 | 7.03e-05 | 466 | 164 | 13 | GSM777050_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | NAALAD2 FN1 FAT3 LAMA1 MR1 SSTR4 SVEP1 HEPH PTK2B HSPA12A FBN2 ANGPTL2 HMCN1 SLFN13 LOX ANTXR1 EGFLAM | 1.05e-04 | 773 | 164 | 17 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | CFAP47 SCRT1 FN1 RSPH4A ENPP2 SVEP1 PCDH17 HOXB7 HSPA12A AMER2 FBN2 DNAH12 HMCN1 RSPH1 LOX SPON2 PLXNA4 SCUBE3 CNTNAP4 FAM181B CDH2 | 1.10e-04 | 1094 | 164 | 21 | ratio_EB_vs_SC_2500_K3 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT3 LAMA1 ADGRV1 PKHD1L1 SVEP1 FBN2 HMCN1 CNTNAP2 CNTNAP4 CPVL | 5.99e-10 | 160 | 169 | 10 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT3 LAMA1 ADGRV1 PKHD1L1 SVEP1 FBN2 HMCN1 CNTNAP2 CNTNAP4 CPVL | 5.99e-10 | 160 | 169 | 10 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.89e-08 | 170 | 169 | 9 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.81e-08 | 178 | 169 | 9 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-08 | 184 | 169 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-08 | 184 | 169 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-08 | 184 | 169 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FNDC3B HSPG2 NAALAD2 ENPP2 SVEP1 ANGPTL2 SPON2 ANTXR1 ADAMTSL2 | 5.39e-08 | 192 | 169 | 9 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FNDC3B HSPG2 NAALAD2 ENPP2 SVEP1 ANGPTL2 SPON2 ANTXR1 ADAMTSL2 | 5.39e-08 | 192 | 169 | 9 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.02e-08 | 198 | 169 | 9 | 7d2fe57e0f9311ac1e6854402ebc154306eb1ba5 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-07 | 161 | 169 | 8 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.16e-07 | 178 | 169 | 8 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-07 | 190 | 169 | 8 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-07 | 190 | 169 | 8 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.82e-07 | 190 | 169 | 8 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-07 | 190 | 169 | 8 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.67e-07 | 193 | 169 | 8 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.67e-07 | 193 | 169 | 8 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.98e-07 | 194 | 169 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.95e-07 | 197 | 169 | 8 | 2f72fd9a5b6d62c24a95ed2246194ea7458c0f12 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.95e-07 | 197 | 169 | 8 | 2cec938caf6ffd031cea37277071487e59b2c71c | |
| ToppCell | P03-Mesenchymal-myocytic_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.95e-07 | 197 | 169 | 8 | 079db904a08743b3c555cb7b3f5fb5c978dde25a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.95e-07 | 197 | 169 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.30e-07 | 198 | 169 | 8 | 196257c4420ac801ed9fbb444f11718adb7560ae | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-Neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 9.30e-07 | 198 | 169 | 8 | 90ebefc9ba8dc2a81471e5693384f5ce56f06298 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.30e-07 | 198 | 169 | 8 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 9.30e-07 | 198 | 169 | 8 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | (02)_MMP9/10+-(1)_GFP|(02)_MMP9/10+ / shred by cell type by condition | 9.66e-07 | 199 | 169 | 8 | 448ba982be804007f991d469eca9d885b21ae499 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.66e-07 | 199 | 169 | 8 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-06 | 154 | 169 | 7 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.68e-06 | 160 | 169 | 7 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 160 | 169 | 7 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 160 | 169 | 7 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.03e-06 | 163 | 169 | 7 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-06 | 167 | 169 | 7 | 3dfec2fcc36caa6e394efae5e540a6fa28759977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-06 | 167 | 169 | 7 | 95b3b5ba3414729f0460a26a0deca48de0cbe33e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-06 | 167 | 169 | 7 | 9480739587d51e67a281778b9bddd7b5ffc3ad92 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.70e-06 | 168 | 169 | 7 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.70e-06 | 168 | 169 | 7 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.42e-06 | 178 | 169 | 7 | 8bae5db100f4563aa1fc7f881e7f8c59d669e37a | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.42e-06 | 178 | 169 | 7 | bc0336692b84bd0fa49747ed5a031b8ed8afa0fd | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.62e-06 | 179 | 169 | 7 | f5bb4d3a27d56698473219970e764084096cc582 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.62e-06 | 179 | 169 | 7 | fa03ec3cc0132f977b4cb28e7b23789732375183 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.83e-06 | 180 | 169 | 7 | 12f3c4c4aa7fe03c0ef847bd4d4942c808015f5f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.83e-06 | 180 | 169 | 7 | 1bc01bb76d0d3f8db74f9244436d3e6d6015ed5d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.83e-06 | 180 | 169 | 7 | 2a28fbfe10a340c8662c2c8be33792f41fc09088 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.04e-06 | 181 | 169 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-06 | 181 | 169 | 7 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.97e-06 | 185 | 169 | 7 | a6cd90f8f30c7bdf66958cf403e73c193aa32f5e | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.97e-06 | 185 | 169 | 7 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.97e-06 | 185 | 169 | 7 | 5053f932e2adfcf4d6faaecff2999ac53d8d7aa5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.48e-06 | 187 | 169 | 7 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | CF-Lymphoid-pDC|Lymphoid / Disease state, Lineage and Cell class | 7.48e-06 | 187 | 169 | 7 | adc79e5804ab98006dbdf1d76ef0d8f85cc5cb0f | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 7.48e-06 | 187 | 169 | 7 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | P15-Mesenchymal|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.75e-06 | 188 | 169 | 7 | f1ba0b661621a65c91432e62ba73531bdf18e7c1 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.75e-06 | 188 | 169 | 7 | ed92cddf47defea2f904d36c7ae05ffa323349a9 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.02e-06 | 189 | 169 | 7 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-06 | 189 | 169 | 7 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.02e-06 | 189 | 169 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 8.02e-06 | 189 | 169 | 7 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 8.02e-06 | 189 | 169 | 7 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.02e-06 | 189 | 169 | 7 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.30e-06 | 190 | 169 | 7 | 3b9abc25b17e7295356ded57ff2ca519fa9f2686 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-06 | 190 | 169 | 7 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.30e-06 | 190 | 169 | 7 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-06 | 190 | 169 | 7 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-06 | 191 | 169 | 7 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.59e-06 | 191 | 169 | 7 | d4f535b06ad483448ab692e9900c872c78cbed60 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-06 | 191 | 169 | 7 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-06 | 191 | 169 | 7 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-06 | 191 | 169 | 7 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.59e-06 | 191 | 169 | 7 | b5210de890d338602857b5907135705a507bc2b0 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 8.89e-06 | 192 | 169 | 7 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.89e-06 | 192 | 169 | 7 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-06 | 192 | 169 | 7 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-06 | 192 | 169 | 7 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-06 | 192 | 169 | 7 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-06 | 192 | 169 | 7 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.89e-06 | 192 | 169 | 7 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | facs-Lung-EPCAM-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | b9ac74357435f2f24aaede62b2a1d31b5d96a12c | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.19e-06 | 193 | 169 | 7 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 9.19e-06 | 193 | 169 | 7 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | fa45042d30f9cfeed10e23270a78f18551219cfa | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 193 | 169 | 7 | cc355b2ed6510619cad969ae074126d7c8db784d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 193 | 169 | 7 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.19e-06 | 193 | 169 | 7 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | ab511ea9e09216a965b3ae5a94f8c3c1ae33d944 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.51e-06 | 194 | 169 | 7 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.51e-06 | 194 | 169 | 7 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-06 | 195 | 169 | 7 | 841fde528ecb293e07b5e00e499d1e9f0b0dce14 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.83e-06 | 195 | 169 | 7 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.83e-06 | 195 | 169 | 7 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.83e-06 | 195 | 169 | 7 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.83e-06 | 195 | 169 | 7 | 1daddd801bd4596fffbdb822fc326d5127c96004 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.83e-06 | 195 | 169 | 7 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.83e-06 | 195 | 169 | 7 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-06 | 195 | 169 | 7 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-05 | 196 | 169 | 7 | f0fd7db22985d2bc84dc8bcbdb2d552e280121dd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 196 | 169 | 7 | 22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b | |
| Computational | Adhesion molecules. | 8.39e-05 | 141 | 108 | 8 | MODULE_122 | |
| Drug | Griseofulvin [126-07-8]; Up 200; 11.2uM; PC3; HT_HG-U133A | TANC2 ZSWIM8 A1CF HECW1 MR1 SVEP1 HSPA12A EDAR RBFOX1 PRKAR1B | 2.23e-06 | 199 | 167 | 10 | 7363_UP |
| Drug | Carcinine [56897-53-1]; Down 200; 22uM; PC3; HT_HG-U133A | 1.33e-05 | 193 | 167 | 9 | 4225_DN | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.44e-05 | 195 | 167 | 9 | 4734_UP | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.56e-05 | 197 | 167 | 9 | 2128_DN | |
| Drug | 0393-0188; Up 200; 10uM; PC3; HT_HG-U133A | 1.56e-05 | 197 | 167 | 9 | 7510_UP | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; PC3; HT_HG-U133A | NAALAD2 SPRED2 ADAMTS13 SRCAP HOXB7 FOXRED2 LOX TRPV4 GAREM1 | 1.56e-05 | 197 | 167 | 9 | 5768_UP |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.56e-05 | 197 | 167 | 9 | 2898_UP | |
| Drug | Laudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.76e-05 | 200 | 167 | 9 | 7030_UP | |
| Drug | Sikvav | 2.65e-05 | 24 | 167 | 4 | CID005487517 | |
| Drug | 2,4-diaminopyrimidine | 4.73e-05 | 54 | 167 | 5 | CID000067431 | |
| Drug | kalinin | 5.17e-05 | 55 | 167 | 5 | CID000032518 | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; MCF7; HT_HG-U133A | 7.43e-05 | 187 | 167 | 8 | 5258_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 8.61e-05 | 191 | 167 | 8 | 6776_UP | |
| Drug | Gramine [87-52-5]; Up 200; 23uM; MCF7; HT_HG-U133A | 8.93e-05 | 192 | 167 | 8 | 2799_UP | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 9.59e-05 | 194 | 167 | 8 | 4246_DN | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 4063_DN | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 7025_UP | |
| Drug | Sulfadiazine [68-35-9]; Up 200; 16uM; HL60; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 1852_UP | |
| Drug | Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 5527_UP | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; HL60; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 2388_DN | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; PC3; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 4549_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 6559_UP | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 2782_UP | |
| Drug | Parbendazole [14255-87-9]; Down 200; 16.2uM; PC3; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 4535_DN | |
| Drug | Amrinone [60719-84-8]; Up 200; 21.4uM; PC3; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 4488_UP | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 5477_DN | |
| Drug | Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 5527_DN | |
| Drug | NSC 523214 | 1.08e-04 | 147 | 167 | 7 | CID000004752 | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 6641_DN | |
| Drug | Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 2305_DN | |
| Drug | Trapidil [15421-84-8]; Up 200; 19.4uM; HL60; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 3136_UP | |
| Drug | Isoniazid [54-85-3]; Up 200; 29.2uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 2246_UP | |
| Drug | Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 3436_UP | |
| Drug | Heptaminol hydrochloride [543-15-7]; Up 200; 22uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 7313_UP | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 2309_UP | |
| Drug | Griseofulvin [126-07-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 4687_UP | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; HL60; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 3113_UP | |
| Drug | Guanadrel sulfate [22195-34-2]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 3698_DN | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; MCF7; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 3333_UP | |
| Drug | Chenodiol [474-25-9]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 6012_UP | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 9.42e-06 | 8 | 165 | 3 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Alzheimer disease, educational attainment | 1.12e-05 | 247 | 165 | 9 | EFO_0011015, MONDO_0004975 | |
| Disease | alopecia areata (is_marker_for) | 2.00e-05 | 10 | 165 | 3 | DOID:986 (is_marker_for) | |
| Disease | Neoplasm Invasiveness | 8.29e-05 | 184 | 165 | 7 | C0027626 | |
| Disease | Spondyloepiphyseal Dysplasia | 9.11e-05 | 16 | 165 | 3 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 9.11e-05 | 16 | 165 | 3 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 9.11e-05 | 16 | 165 | 3 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 9.11e-05 | 16 | 165 | 3 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 9.11e-05 | 16 | 165 | 3 | C0025237 | |
| Disease | Alzheimer disease | HECW1 WDR70 PTK2B EDAR SLC4A1AP RBFOX1 CNTNAP2 ANTXR1 SETD7 MYO15A SORL1 | 9.60e-05 | 485 | 165 | 11 | MONDO_0004975 |
| Disease | Van Buchem disease | 1.10e-04 | 17 | 165 | 3 | C0432272 | |
| Disease | Osteochondrodysplasias | 1.56e-04 | 19 | 165 | 3 | C0029422 | |
| Disease | Dyschondroplasias | 1.56e-04 | 19 | 165 | 3 | C0013366 | |
| Disease | cortical thickness | HSPG2 FLNB VRK2 MYCBP2 ENPP2 FAT3 LAMA1 MR1 ADGRV1 PCDH17 FBN2 KMT2A EXOC2 CPVL KDM4B AGAP1 AGAP3 | 1.77e-04 | 1113 | 165 | 17 | EFO_0004840 |
| Disease | Multiple Epiphyseal Dysplasia | 1.83e-04 | 20 | 165 | 3 | C0026760 | |
| Disease | insomnia measurement | TANC2 VRK2 MYCBP2 RBM4B RBFOX1 FIBCD1 KMT2A KDM4B AGAP1 SORL1 | 2.08e-04 | 443 | 165 | 10 | EFO_0007876 |
| Disease | Neoplasm Metastasis | 2.30e-04 | 217 | 165 | 7 | C0027627 | |
| Disease | glaucoma | 2.37e-04 | 154 | 165 | 6 | MONDO_0005041 | |
| Disease | Adenoid Cystic Carcinoma | 2.52e-04 | 100 | 165 | 5 | C0010606 | |
| Disease | prostate cancer (is_marker_for) | 2.54e-04 | 156 | 165 | 6 | DOID:10283 (is_marker_for) | |
| Disease | Antiglaucoma preparations and miotics use measurement | 4.06e-04 | 26 | 165 | 3 | EFO_0009944 | |
| Disease | diabetic angiopathy (implicated_via_orthology) | 4.59e-04 | 6 | 165 | 2 | DOID:11713 (implicated_via_orthology) | |
| Disease | stroke outcome severity measurement | 4.62e-04 | 114 | 165 | 5 | EFO_0009603 | |
| Disease | Grand Mal Status Epilepticus | 5.49e-04 | 67 | 165 | 4 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 5.49e-04 | 67 | 165 | 4 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 5.49e-04 | 67 | 165 | 4 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 5.49e-04 | 67 | 165 | 4 | C0751523 | |
| Disease | Petit mal status | 5.49e-04 | 67 | 165 | 4 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 5.49e-04 | 67 | 165 | 4 | C0393734 | |
| Disease | Hematopoetic Myelodysplasia | 5.64e-04 | 29 | 165 | 3 | C2713368 | |
| Disease | Status Epilepticus | 5.81e-04 | 68 | 165 | 4 | C0038220 | |
| Disease | Spondylometaphyseal dysplasia | 6.41e-04 | 7 | 165 | 2 | cv:C4759767 | |
| Disease | Type II Collagenopathies | 6.41e-04 | 7 | 165 | 2 | cv:CN043672 | |
| Disease | Prostatic Neoplasms | SAMD9 ACRBP KAT6A NDST2 SESN3 SPON2 KMT2A ENPP5 CDH1 DNMT1 TJP3 | 7.31e-04 | 616 | 165 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | SAMD9 ACRBP KAT6A NDST2 SESN3 SPON2 KMT2A ENPP5 CDH1 DNMT1 TJP3 | 7.31e-04 | 616 | 165 | 11 | C0376358 |
| Disease | open-angle glaucoma | 7.42e-04 | 191 | 165 | 6 | EFO_0004190 | |
| Disease | xerostomia | 8.51e-04 | 8 | 165 | 2 | EFO_0009869 | |
| Disease | Cornelia De Lange Syndrome | 8.51e-04 | 8 | 165 | 2 | C0270972 | |
| Disease | pit and fissure surface dental caries | 9.85e-04 | 35 | 165 | 3 | EFO_0006338 | |
| Disease | Primary ciliary dyskinesia | 1.07e-03 | 36 | 165 | 3 | cv:C0008780 | |
| Disease | choroid plexus volume measurement | 1.09e-03 | 9 | 165 | 2 | EFO_0010293 | |
| Disease | Disorder of fatty acid metabolism | 1.09e-03 | 9 | 165 | 2 | cv:C0268634 | |
| Disease | 3-phenylpropionate hydrocinnamate measurement | 1.36e-03 | 10 | 165 | 2 | EFO_0021010 | |
| Disease | multiple system atrophy | 1.46e-03 | 40 | 165 | 3 | EFO_1001050 | |
| Disease | cortical surface area measurement | TANC2 FLNB DCHS2 VRK2 SAMD9 MYCBP2 ENPP2 FAT3 DAPK1 ADGRV1 SVEP1 FBN2 ANGPTL2 EXOC2 CPVL AGAP1 AGAP3 | 1.48e-03 | 1345 | 165 | 17 | EFO_0010736 |
| Disease | vital capacity | HSPG2 VRK2 SPRED2 FN1 ENPP2 WDR70 SVEP1 HMCN1 EDAR PIK3C2B LOX ANTXR1 CDH2 KDM4B AGAP1 AGAP3 | 1.60e-03 | 1236 | 165 | 16 | EFO_0004312 |
| Disease | Prostatic Intraepithelial Neoplasias | 1.65e-03 | 11 | 165 | 2 | C0282612 | |
| Disease | Aortic Valve Insufficiency | 1.65e-03 | 11 | 165 | 2 | C0003504 | |
| Disease | susceptibility to plantar warts measurement | 1.66e-03 | 90 | 165 | 4 | EFO_0008406 | |
| Disease | household income | 1.67e-03 | 304 | 165 | 7 | EFO_0009695 | |
| Disease | volumetric bone mineral density | 1.68e-03 | 42 | 165 | 3 | EFO_0007620 | |
| Disease | Charcot-Marie-Tooth disease | 1.68e-03 | 42 | 165 | 3 | cv:C0007959 | |
| Disease | Childhood Medulloblastoma | 1.80e-03 | 43 | 165 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 1.80e-03 | 43 | 165 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 1.80e-03 | 43 | 165 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 1.80e-03 | 43 | 165 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 1.80e-03 | 43 | 165 | 3 | C0278876 | |
| Disease | age at assessment, pelvic organ prolapse | 1.80e-03 | 43 | 165 | 3 | EFO_0004710, EFO_0008007 | |
| Disease | phenylacetylglutamine measurement | 1.98e-03 | 12 | 165 | 2 | EFO_0021013 | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 1.98e-03 | 12 | 165 | 2 | DOID:3319 (is_marker_for) | |
| Disease | Primary Ciliary Dyskinesia | 2.32e-03 | 47 | 165 | 3 | C4551720 | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 2.33e-03 | 13 | 165 | 2 | C0369183 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 2.33e-03 | 13 | 165 | 2 | C1261502 | |
| Disease | tyrosine-protein kinase receptor Tie-1, soluble measurement | 2.33e-03 | 13 | 165 | 2 | EFO_0008312 | |
| Disease | intraocular pressure measurement | 2.36e-03 | 509 | 165 | 9 | EFO_0004695 | |
| Disease | myopathy (implicated_via_orthology) | 2.47e-03 | 48 | 165 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | CD209 antigen measurement | 2.71e-03 | 14 | 165 | 2 | EFO_0008077 | |
| Disease | Medulloblastoma | 2.78e-03 | 50 | 165 | 3 | C0025149 | |
| Disease | Mammary Carcinoma, Human | 2.90e-03 | 525 | 165 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.90e-03 | 525 | 165 | 9 | C1257931 | |
| Disease | retinal drusen | 2.94e-03 | 51 | 165 | 3 | EFO_1001155 | |
| Disease | Mammary Neoplasms | 2.97e-03 | 527 | 165 | 9 | C1458155 | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 3.11e-03 | 15 | 165 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | glycerate measurement | 3.11e-03 | 15 | 165 | 2 | EFO_0021029 | |
| Disease | urinary bladder cancer (is_marker_for) | 3.11e-03 | 107 | 165 | 4 | DOID:11054 (is_marker_for) | |
| Disease | Breast Carcinoma | 3.40e-03 | 538 | 165 | 9 | C0678222 | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 3.78e-03 | 352 | 165 | 7 | EFO_0007014 | |
| Disease | optic cup area measurement | 3.83e-03 | 56 | 165 | 3 | EFO_0006940 | |
| Disease | FEV/FEC ratio | FNDC3B HSPG2 DCHS2 COTL1 DNAH12 HMCN1 LOX CNTNAP2 SCUBE3 ANTXR1 EXOC2 MYO15A CPVL SORL1 AGAP3 | 3.85e-03 | 1228 | 165 | 15 | EFO_0004713 |
| Disease | Charcot-Marie-Tooth disease type 2 | 4.00e-03 | 17 | 165 | 2 | cv:C0270914 | |
| Disease | HbA1c measurement | FNDC3B B3GLCT ETFDH IP6K1 ADAMTS13 COTL1 FN3K MYO15A CDH1 CPVL | 4.84e-03 | 675 | 165 | 10 | EFO_0004541 |
| Disease | health study participation | 4.90e-03 | 195 | 165 | 5 | EFO_0010130 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 4.99e-03 | 19 | 165 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | diet measurement, HOMA-B | 4.99e-03 | 19 | 165 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | glomerulonephritis (is_marker_for) | 4.99e-03 | 19 | 165 | 2 | DOID:2921 (is_marker_for) | |
| Disease | pulse pressure measurement | FNDC3B FLNB CDSN B3GLCT FN1 ENPP2 FAT3 ETFDH SRCAP AHDC1 SVEP1 HOXB7 FBN2 SNRNP70 KDM4B DNMT1 | 5.12e-03 | 1392 | 165 | 16 | EFO_0005763 |
| Disease | glaucoma (is_marker_for) | 5.53e-03 | 20 | 165 | 2 | DOID:1686 (is_marker_for) | |
| Disease | freckles | 5.53e-03 | 20 | 165 | 2 | EFO_0003963 | |
| Disease | melanoma | 5.56e-03 | 126 | 165 | 4 | EFO_0000756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEKYDPGYEAAYGGA | 331 | Q13569 | |
| YLTGTYVQEESPEGG | 111 | Q96P47 | |
| DYYDTGEELGSGQFA | 11 | P53355 | |
| SGDALYDLYADPDGS | 551 | Q8N7J2 | |
| GYYGCDEELVGPLYA | 21 | P78357 | |
| FRPDSGDGVLLYSYD | 641 | Q63HQ2 | |
| YLTGTYVQEESPEGG | 91 | Q9UPQ3 | |
| GPACYGGFDLYFILD | 36 | Q9H6X2 | |
| YDSGEPVFLGERYGY | 366 | Q6Y288 | |
| PESLLEGDDGKTYFY | 851 | P26358 | |
| YEVYPTFAVTARGDG | 576 | Q9NQ94 | |
| PKSGGDYAYVTEIFG | 101 | Q9NS82 | |
| VDTEDFQPGLYYSGR | 626 | Q96Q42 | |
| EECTYDYVAVLGGPG | 196 | Q5VXM1 | |
| GSPESGRFYGLDLYG | 421 | Q8NEB7 | |
| GFAQILIPGDAYTDY | 146 | Q5MAI5 | |
| SLYDPVCGSDGVTYG | 496 | O00468 | |
| DIADPVSGLFYFGEG | 4571 | Q8WXG9 | |
| RGFVPAAYEEFEYGG | 606 | A8MVX0 | |
| FEYGGEIFALPAPYD | 616 | A8MVX0 | |
| FYYIDSDGSGPLEPF | 606 | Q9C0A0 | |
| GFGPVADDGYGVSYI | 711 | P50416 | |
| GFEGTEEGSPREFIY | 26 | Q9UKU9 | |
| FQDSPDLGLDYYSGD | 1306 | Q5TGY3 | |
| RESEGLYGQPGDETY | 736 | Q15057 | |
| YEVVGGSSDSYLVPG | 296 | Q15517 | |
| GLPLTGEYYVENADG | 1376 | Q6W2J9 | |
| PSSVAGYGDIYLNAG | 1401 | Q14004 | |
| YGEEYGNLTRPDITF | 661 | Q76LX8 | |
| GGYESESAYPNAELV | 356 | Q13613 | |
| TQGFEETGDTLYAPY | 306 | Q8NFJ5 | |
| DEGPNGEVLYSFSSY | 271 | O14917 | |
| DLNEELYLGGYPDYG | 3791 | P98160 | |
| ELPLTAGDYIYIFGD | 856 | A6NNM3 | |
| ELPLTAGDYIYIFGD | 856 | A6NJZ7 | |
| VIGGYADGESFLGYV | 156 | P28070 | |
| YYEGAFVDGEITGEG | 61 | Q5T089 | |
| GGLDYEDSGFYDIDV | 336 | Q9Y5G9 | |
| GEVFDFSTYYLGGIP | 2706 | Q16787 | |
| YGEYFPGTGDLRDIG | 201 | Q13547 | |
| YTVPYAEGVYGGGDE | 376 | Q9UKN7 | |
| VYTSGGDPESVAGEY | 246 | Q9Y262 | |
| YVTFVGEEGLDYSGP | 1281 | Q76N89 | |
| GDPYYIGLTGLELYD | 1411 | O60303 | |
| PYLSCGYGTKDEDYG | 56 | Q9UNE0 | |
| YFLEETGPNSTSYLG | 456 | O95822 | |
| AGIYTEDITGDTYGP | 601 | Q86SJ6 | |
| QPGAAYFYVELDTGE | 461 | Q69YN2 | |
| GDGYSDPESIIGGYA | 236 | Q9H3G5 | |
| DPESIIGGYAEFLYQ | 241 | Q9H3G5 | |
| YFDIYTAGAGVGDIG | 376 | O75369 | |
| DLDGAGIPFLDYRTY | 1306 | Q9HCM2 | |
| SFGPRYGFVYELETG | 106 | P20941 | |
| IVGSLEPGIYAGYFD | 771 | Q96KP1 | |
| AFIGAYGETYPAIED | 1101 | Q1MSJ5 | |
| DQEGSYPYFIGVSLG | 426 | Q9UJA9 | |
| YSSGEQLFGLPVTDY | 1251 | Q96JB1 | |
| LPYQDSGDSGSDYLF | 421 | Q9H706 | |
| SPEDGVYIHGLYLDG | 2986 | Q6ZR08 | |
| PIYGADISGSLYDDD | 131 | O94953 | |
| PIYYGFSESAESQGL | 341 | Q86TH1 | |
| EGSYDGAYAPVLQDF | 1256 | P00451 | |
| ATGGPYGSLGVDYEF | 341 | O43301 | |
| AVEFFELLGPDYGAG | 261 | A6NEQ2 | |
| DFPGSEYAEGYESVS | 191 | Q8IWF2 | |
| VGEGYGYGPESELSQ | 316 | Q9BQ04 | |
| ATYGGSDDYIGLALP | 1416 | Q6R327 | |
| YEENGTDLSGAGDPY | 436 | Q9H074 | |
| LYVVSPGGEESGEYV | 1036 | Q96RW7 | |
| GSLSGDYLYIFDGSD | 121 | O00750 | |
| DYLYIFDGSDGGVSS | 126 | O00750 | |
| FDAGPYGELTYSIVS | 2796 | Q6V1P9 | |
| AGVYAAGYGLEPSSF | 71 | P09629 | |
| YLGYSVAVGEFSGDD | 271 | P08648 | |
| IYERIPGDFGAGSYS | 1731 | Q92794 | |
| PEEGTGGFDGIYYGD | 41 | Q5T0Z8 | |
| SGYSGGLALAEYDQP | 356 | O14976 | |
| GGLPQFGDEYDFYRS | 51 | Q01780 | |
| GVEVYPGYAAAEVLF | 191 | Q16134 | |
| YDYSVEFTGVGEPPA | 201 | Q5T8I9 | |
| GGAGVVPGESYSAEY | 286 | O43837 | |
| QGDIPTFYTYEEGLS | 161 | P54105 | |
| RYGLGGSCPDEYDFS | 21 | Q96M89 | |
| YDGSTIVPGEQGAEY | 31 | Q14019 | |
| VGSYGPRAEEYEFLT | 146 | P52565 | |
| GYYTVTGLEPGIDYD | 1321 | P02751 | |
| LNDGGYGPYSDVSEI | 746 | Q53EP0 | |
| GAYLVPSYSFGENEV | 216 | Q6ZPD8 | |
| GDYGYPADVLFSSRL | 226 | P49326 | |
| DVDDYRFVYAGPAGS | 216 | Q9H9V9 | |
| TDGDPGTYGQISYAI | 2521 | Q8TDW7 | |
| PYDSLLVFDYEGSGS | 861 | P55283 | |
| GLSPGCYDTYGADID | 346 | P28300 | |
| EDGYPLTVADYSGTA | 361 | Q8N539 | |
| FEGDSDGYINLVAYP | 81 | Q92551 | |
| ETGAYLIDRDPTYFG | 86 | Q9NXV2 | |
| EYVEVGRLGPSDYFG | 311 | P31321 | |
| GVRSYGEEDIPFYSS | 2636 | Q03164 | |
| DYLDLDYEITFGGIP | 306 | Q9UHC6 | |
| GYLDTLEGSFTSPNY | 156 | Q86UP6 | |
| YGLGYDCPATEGIFD | 96 | Q9BY41 | |
| STEYYTLCPGGEGFR | 1626 | P35556 | |
| LGEGFFGEVYEGVYT | 431 | Q14289 | |
| GELGDFTGYIESPNY | 811 | Q9NQ36 | |
| GELGEFTGYIESPNY | 806 | Q8IX30 | |
| FYPGEYVGYLVDAEG | 4176 | Q9NZJ4 | |
| VDAEGGDIYGSYQPT | 4186 | Q9NZJ4 | |
| PEYISAFANTEGGYL | 231 | Q68D06 | |
| YSYDDTDIGLEPGSG | 661 | Q6ZTR5 | |
| EAYYSDIQEAIPSGG | 1071 | Q8TDX9 | |
| PYDSLLVFDYEGSGS | 851 | P19022 | |
| VNVISGPIFDYDYDG | 731 | Q13822 | |
| PYDSLLVFDYEGSGS | 826 | P12830 | |
| ASSELFEPYYGEGGI | 316 | Q8N1G2 | |
| FEPYYGEGGIDGDGD | 321 | Q8N1G2 | |
| EIDYGDILPSGDGTY | 246 | Q95460 | |
| EEQEETGSGPAGYSY | 56 | Q16626 | |
| YFEQAGVGLGTDETY | 321 | Q5TD94 | |
| ESEGGDGYLAPENGY | 416 | P08621 | |
| GAVYSPEFYAGTVLL | 216 | Q9NWB1 | |
| PLAGGVTTFVALYDY | 81 | P12931 | |
| LENVLYYSPGGAGSD | 386 | Q92673 | |
| GLVDSAGTGDLSYGY | 371 | Q8NBJ9 | |
| LSDYVGPSSVYDGDA | 41 | Q9BWW7 | |
| ALDLYPYDAGTDSGF | 181 | Q9BUD6 | |
| ELPLTAGDYIYIFGD | 856 | Q9UFD9 | |
| SFYLGFSIGGPLAYD | 1571 | Q5K651 | |
| DVEGLFYLGGLPSQY | 2831 | P25391 | |
| FYEKDSEGSLYPDGS | 131 | Q9BQS7 | |
| DDVGPIIYDPASFYG | 226 | Q9H479 | |
| GTDFSPDVGYNGYTR | 371 | Q5JRX3 | |
| GSDEGTEYYPHLVFL | 356 | Q9H0W8 | |
| AGGAEEEPLDYYATA | 336 | P31391 | |
| IYYPDGGSLVGEVNE | 121 | Q8WTS6 | |
| TLGYGEDATPGTGYT | 111 | P21815 | |
| ESGLTPLGYAAAAGY | 916 | Q9HCD6 | |
| FSVYGGGGIHEYELE | 1761 | O75592 | |
| ARLPNGDTYEGSYEF | 36 | Q8WYR4 | |
| LGEFLAYPYVDPGTF | 396 | Q92966 | |
| YAGAYAPGSGSSEDE | 451 | Q6ZRS2 | |
| PIENGFVEGADYSYG | 2561 | Q4LDE5 | |
| FYTDFVGEGLYQGVP | 291 | Q96JT2 | |
| DDFPAPSDGYYRGEG | 56 | Q7L0J3 | |
| PSDGYYRGEGTQDEE | 61 | Q7L0J3 | |
| GETFLPYYTGRAIDG | 201 | Q9NP78 | |
| PEDALYGFDSYGPVT | 146 | Q14592 | |
| TDEPGYYEDGAFGIR | 521 | Q9NQW7 | |
| ERLYVTYFGGDEAAG | 131 | P49588 | |
| TSDVSRYIEDPGFGY | 321 | P58005 | |
| YSPDGQYIVTGGDDG | 381 | Q15269 | |
| DPSGARLVTGGYDYD | 191 | Q9NW82 | |
| LRSGEEGYYPELTEF | 46 | Q07617 | |
| PETELGEYSLGGYSI | 26 | Q96S82 | |
| TIFYNEYPGGSRELD | 491 | P52849 | |
| YPYVDSSDFGLGEDP | 266 | Q7Z698 | |
| SGITGEPLEAYIYFG | 991 | Q9NW08 | |
| FVGRSEATYAYGGPE | 1511 | Q86WI1 | |
| PEELSLAFVYGSGVY | 21 | Q96BW9 | |
| DYEAGVLAFYDVTGG | 396 | Q14142 | |
| NYEPGVLGYFEFSGS | 231 | Q6PKC3 | |
| AVAGEADVPFYYASG | 391 | Q96TA2 | |
| TYEEDGGVYFSEGPE | 666 | A7E2V4 | |
| GYTDGEGGPYTDVDD | 821 | O95049 | |
| FPGGILSFYGVEYDT | 501 | O95361 | |
| FTSIEPGYYKDGEFG | 551 | O43895 | |
| GSQVPYYLELEASGF | 316 | Q9Y4F4 | |
| PAEGGYGDEQIYSAS | 226 | Q53EQ6 | |
| GYSKLHDDLGEFPYG | 101 | O75845 | |
| KDEGGYFYFGELPLS | 276 | Q9HBA0 | |
| DYLGIPLFYGSGLTE | 96 | Q86Y07 | |
| LYLSSEYEAAPGSFG | 451 | Q9H5J0 | |
| GAIGIILYSDPADYF | 211 | Q9Y3Q0 | |
| GSDYEYSEGTLVFKP | 441 | Q9UPR5 | |
| DGECDSNGPGFYLYD | 221 | Q9BWU0 | |
| GDYTFVPDGYALSLS | 506 | Q14324 |